RIGL
Rigel Pharmaceuticals Inc
Price:  
0.91 
USD
Volume:  
655,626.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RIGL WACC - Weighted Average Cost of Capital

The WACC of Rigel Pharmaceuticals Inc (RIGL) is 7.8%.

The Cost of Equity of Rigel Pharmaceuticals Inc (RIGL) is 8.20%.
The Cost of Debt of Rigel Pharmaceuticals Inc (RIGL) is 9.40%.

Range Selected
Cost of equity 6.70% - 9.70% 8.20%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 11.80% 9.40%
WACC 6.3% - 9.4% 7.8%
WACC

RIGL WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.61 0.86
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.70% 9.70%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.37 0.37
Cost of debt 7.00% 11.80%
After-tax WACC 6.3% 9.4%
Selected WACC 7.8%